Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medicinova (MNOV) Operating Expenses (2021 - 2025)

Medicinova (MNOV) has disclosed Operating Expenses for 7 consecutive years, with $3.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Expenses changed N/A to $3.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.8 million, a N/A change, with the full-year FY2025 number at $13.7 million, up 8.03% from a year prior.
  • Operating Expenses was $3.2 million for Q4 2025 at Medicinova, down from $3.4 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $4.3 million in Q2 2021 to a low of -$497149.0 in Q4 2023.
  • A 5-year average of $3.1 million and a median of $3.3 million in 2023 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: plummeted 44.92% in 2023, then skyrocketed 54.14% in 2024.
  • Medicinova's Operating Expenses stood at $2.1 million in 2021, then surged by 85.34% to $3.9 million in 2022, then plummeted by 112.76% to -$497149.0 in 2023, then soared by 765.62% to $3.3 million in 2024, then decreased by 1.96% to $3.2 million in 2025.
  • Per Business Quant, the three most recent readings for MNOV's Operating Expenses are $3.2 million (Q4 2025), $3.4 million (Q3 2025), and $3.2 million (Q1 2025).